ArticleBlood advances2023

Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes.

Sergiu Pasca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.